Does Point of Care Ultrasound Change Needle Insertion Location During Routine Bedside Paracentesis?
1 other identifier
interventional
45
1 country
1
Brief Summary
Paracentesis is a bedside procedure in which a needle is inserted into a patient's peritoneum in order to obtain ascitic fluid. This is a safe bedside procedure with very low risks of complications that is usually performed using physical exam maneuvers to determine the site of needle insertion. Point of care ultrasound (POCUS) technology has improved the safety of central venous catheter insertion and thoracentesis, yet the data on safety in paracentesis is equivocal. In a practical study, we aim to determine if POCUS will change the needle insertion site over the traditional anatomic landmarking method. Operators will landmark for paracentesis using conventional physical exam and then utilize POCUS to determine if there is a more optimal site. The primary endpoint will be whether POCUS yielded a change in the needle insertion site, as defined by a location greater than 5cm from the anatomic site, at least 20% of the time. The results will further our understanding of POCUS in improving procedural safety, thereby adding to the currently limited literature on this topic. Furthermore, this study will inform residency training programs about the utility in POCUS training for paracentesis and may advocate for the availability of POCUS devices to physicians performing this procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 25, 2020
CompletedFirst Posted
Study publicly available on registry
January 29, 2020
CompletedStudy Start
First participant enrolled
February 7, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2021
CompletedApril 3, 2024
April 1, 2024
1.1 years
January 25, 2020
April 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Preference of land-marking method
Does the clinician performing the procedure prefer the needle insertion site found using point of care ultrasound, or using the traditional anatomic method. A clinically significant difference in location is defined as greater than or equal to 5cm apart. If the difference in locations is not at least 5cm apart, this will be defined as no preference in land-marking methods.
Determined immediatly after the POCUS landmarking is done.
Secondary Outcomes (2)
Depth of Ascitis
Determined immediatly after the POCUS landmarking is done.
Immediate Complications
Occuring at any time between the needle insertion and removal of the paracentesis drain.
Study Arms (1)
All Participants
EXPERIMENTALInterventions
Participants will be have their needle insertion site for a paracentesis land-marked using both the traditional anatomical method, and with a point of care ultrasound. Note that the current standard of care does not require the use of point of care ultrasound.
Eligibility Criteria
You may qualify if:
- Participants scheduled to have either a diagnostic of therapeutic paracentesis.
- Participants can be either inpatients under the care of general internal medicine, or outpatients under the care of gastroenterology or general internal medicine.
- Operators will be recruited on a volunteer basis and will include medical residents or subspecialty fellows with knowledge of POCUS for paracentesis purposes, either through core residency programs or more advanced training.
You may not qualify if:
- Loculated ascites
- Current anticoagulation
- Hemodynamic instability
- Bowel obstruction
- Pregnancy
- Abdominal wall cellulitis
- Platelet count \<20
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Steven Montaguelead
Study Sites (1)
Kingston Health Sciences Center
Kingston, Ontario, K7K2V7, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven Montague, MD
Queen's University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Medical Doctor, Assistant Professor
Study Record Dates
First Submitted
January 25, 2020
First Posted
January 29, 2020
Study Start
February 7, 2020
Primary Completion
March 1, 2021
Study Completion
March 1, 2021
Last Updated
April 3, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will not share